Doug Schenkel
Stock Analyst at Wolfe Research
(3.65)
# 819
Out of 5,033 analysts
68
Total ratings
56%
Success rate
35.15%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Upgrades: Outperform | $75 | $70.20 | +6.84% | 3 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Initiates: Outperform | $32 | $31.50 | +1.59% | 1 | Jul 14, 2025 | |
| TEM Tempus AI | Initiates: Outperform | $60 | $92.45 | -35.10% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $71.87 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $32.74 | +83.26% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $25.86 | +8.28% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $274.90 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $154.54 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $3.52 | - | 1 | Nov 14, 2024 | |
| DHR Danaher | Upgrades: Outperform | $285 | $208.39 | +36.76% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $38.11 | - | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $143.00 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $52 | $48.67 | +5.81% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $13.14 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $99.50 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $62.73 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $543.84 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $7.85 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $95.31 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.98 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $15.18 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $188.60 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $343.18 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.19 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $4.81 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.37 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $9.00 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.19 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $8.44 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $2.74 | +556.93% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $15.54 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $326.85 | -72.46% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.90 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $193.15 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $68.43 | -76.62% | 2 | Sep 28, 2017 |
Guardant Health
Sep 25, 2025
Upgrades: Outperform
Price Target: $75
Current: $70.20
Upside: +6.84%
Caris Life Sciences
Jul 14, 2025
Initiates: Outperform
Price Target: $32
Current: $31.50
Upside: +1.59%
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $92.45
Upside: -35.10%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $71.87
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $32.74
Upside: +83.26%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $25.86
Upside: +8.28%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $274.90
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $154.54
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $3.52
Upside: -
Danaher
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $208.39
Upside: +36.76%
Sep 30, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $38.11
Upside: -
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $143.00
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $52
Current: $48.67
Upside: +5.81%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $13.14
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $99.50
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $62.73
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $543.84
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $7.85
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $95.31
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.98
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $15.18
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $188.60
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $343.18
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.19
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $4.81
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.37
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $9.00
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.19
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $8.44
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $2.74
Upside: +556.93%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $15.54
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $326.85
Upside: -72.46%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $5.90
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $193.15
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $68.43
Upside: -76.62%